BI
BioGaia AB (publ)
BIOGY · OTC
$12.45 +0.00% (+$0.00)
1M +0.81%
Market Cap 12.0B kr
P/E Ratio 34.68x
Div. Yield 3.40%
ROE 27.53%
Bulios Fair Price
$8.68
30.3% downside
Trenutna cena
$12.45
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BIOGY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
14 /100
Expensive P/B 10.91x
P/S 7.62x
P/E 34.68x
Growth
36 /100
Stable Book val. growth 12.66%
FCF growth 0.21%
EPS growth 3.84%
Profitability
100 /100
Strong FCF margin 18.86%
Op. margin 28.10%
Gross margin 73.01%
Quality
100 /100
Excellent Asset turnover 1.18x
ROA 25.91%
ROIC 30.77%
Debt
100 /100
Low Net debt/EBITDA -0.94x
Int. coverage 77.15x
Debt/Equity 0.00x
Stability
83 /100
Stable Profitable years 6
EPS volatility 1.65%
Beta 0.32x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BIOGY
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Theresa Agnew
Employees
242
Headquarters
Stockholm
Prihajajoči dogodki
22 OKT.
Earnings
Upcoming earnings report